fludarabine and Invasiveness, Neoplasm

fludarabine has been researched along with Invasiveness, Neoplasm in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aymerich, M; Campo, E; Colomer, D; López-Guerra, M; López-Otín, C; Matas-Céspedes, A; Montraveta, A; Pérez-Galán, P; Roldán, J; Rosich, L; Roué, G; Villamor, N; Xargay-Torrent, S1
Zhang, L; Zou, W1
Aurran-Schleinitz, T; Birsen, R; Bonnet, C; Boubaya, M; Choquet, S; Cymbalista, F; Delarue, R; Dietrich, PY; Dupuis, J; Fahri, J; Lamy, T; Leblond, V; Lemal, R; Lepretre, S; Levy, V; Michallet, AS; Re, D; Troussard, X; Wanquet, A; Ysebaert, L1
Argyrakos, T; Galani, V; Grigoriou, E; Harhalakis, N; Kanavaros, P; Kapsimali, V; Karmiris, T; Naum, C; Nikiforakis, E; Pantelidaki, C; Rontogianni, D; Tsantekidou, M1

Reviews

1 review(s) available for fludarabine and Invasiveness, Neoplasm

ArticleYear
Blastic natural killer (NK)-cell lymphoma: report of an unusual CD4 negative case and review of the CD4 negative neoplasms with blastic features in the literature.
    Leukemia & lymphoma, 2004, Volume: 45, Issue:10

    Topics: Adult; Blast Crisis; Bone Marrow Neoplasms; CD4 Antigens; Diagnosis, Differential; Fatal Outcome; Humans; Immunophenotyping; In Situ Hybridization; Killer Cells, Natural; Lymphoma, Non-Hodgkin; Male; Neoplasm Invasiveness; RNA, Viral; Skin Neoplasms; Vidarabine

2004

Other Studies

3 other study(ies) available for fludarabine and Invasiveness, Neoplasm

ArticleYear
The γ-secretase inhibitor PF-03084014 combined with fludarabine antagonizes migration, invasion and angiogenesis in NOTCH1-mutated CLL cells.
    Leukemia, 2015, Volume: 29, Issue:1

    Topics: Aged; Amyloid Precursor Protein Secretases; Enzyme Inhibitors; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Mutation; Neoplasm Invasiveness; Neoplasm Metastasis; Neovascularization, Pathologic; Receptor, Notch1; Tetrahydronaphthalenes; Tumor Cells, Cultured; Valine; Vidarabine

2015
Inhibition of integrin β1 decreases the malignancy of ovarian cancer cells and potentiates anticancer therapy via the FAK/STAT1 signaling pathway.
    Molecular medicine reports, 2015, Volume: 12, Issue:6

    Topics: Antineoplastic Agents; Apoptosis; Bevacizumab; Cell Adhesion; Cell Line, Tumor; Cell Movement; Disease Progression; Drug Synergism; Female; Focal Adhesion Kinase 1; Gene Expression Regulation, Neoplastic; Humans; Integrin beta1; Neoplasm Invasiveness; Ovarian Neoplasms; Signal Transduction; Vidarabine

2015
Management of central nervous system involvement in chronic lymphocytic leukaemia: a retrospective cohort of 30 patients.
    British journal of haematology, 2017, Volume: 176, Issue:1

    Topics: Adenine; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Cohort Studies; Disease Management; Disease-Free Survival; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemic Infiltration; Male; Middle Aged; Neoplasm Invasiveness; Piperidines; Prognosis; Pyrazoles; Pyrimidines; Remission Induction; Retrospective Studies; Survival Analysis; Vidarabine

2017